Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. financials at a glance

+ Portfolio

The revenue of Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. is reported as 1.92235 billion Pounds in the fiscal year 2023. The earnings were 0.17 Pounds per share in 2023, which was 6.25 higher than 2022. And about -0.13533 billion Pounds are reported as free cash flow in the financials of Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. 2023. No dividends were paid to the shareholders of the Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. stock CASE:RMDA in the financial year 2023.

£1.92B

Revenue

£0.17

Earnings Per Share

47.03%

Gross Margin %

£122.00M

Free Cash Flow

Revenue

1,922.35

Earnings Per Share

0.17

Gross Margin %

47.03

Free Cash Flow

122.00

Financials

Year	Year	TTM	2023	2022	2021	2020	2019
Rev.	Revenue	N/A	£1.92B	£1.48B	£1.25B	£960.17M	£893.97M
GM %	Gross Margin %	46.71%	47.03%	48.43%	46.28%	46.43%	45.29%
OM	Operating Margin	21.96%	23.19%	23.06%	22.01%	19.48%	24.04%
EPS	Earnings Per Share	£0.15	£0.17	£0.16	£0.12	£0.06	£0.05
Div.	Dividends	N/A	£0.05	£0.03	£0.00	£0.00	£0.00
PR %	Payout Ratio %	0	29.41%	18.75%	0	0	0.00%
Sha.	Shares	N/AM	1,490.53M	1,490.53M	1,522.53M	1,522.53M	1,522.53M
OCF	Operating Cash Flow	N/A	£-44.50M	£29.35M	£241.35M	£-,164.32M	£53.21M
FCF	Free Cash Flow	N/A	£122.00M	£-5.03M	£188.68M	£-,365.45M	£70.35M
FCFS	Free Cash Flow Per Share	£-0.28	£-0.20	£-0.07	£0.00	£-0.37	£-0.06

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. financials at a glance

Financials

Discover